FREE Account Opening + No Clearing Fees
June 14, 2010 - June 17, 2010

Parabolic Drugs IPO Review & Recommendations

and recommend to "Avoid" the IPO.

Parabolic Drugs IPO Review Summary from brokers and analysts

Review By Apply May Apply Neutral Avoid Not Rated
Count 0 0 0 2 0
% 0.00 0.00 0.00 100.00 0.00

Parabolic Drugs IPO Analysis By Brokers/Analysts

Reviewer Recommendation Past Reviews

Parabolic Drugs IPO Capital Market Rating

The Captial Market ( rating for Parabolic Drugs IPO is 35. Their analysis recommends Do not subscribe for the IPO.

Reviewer Rating Score Rating
Capital Market 35 Do not subscribe

Post Recommendation Manage Recommendations


  • The recommendations or analysis of public issues posted above expresses the views of its author and does not represent the views of or its staff.
  • We reserve the right to remove any objectionable post without providing a reason.